Tzu-Ming Pan | Biology and Life Sciences | Innovative Research Award

Innovative Research Award

Tzu-Ming Pan
National Taiwan University, Taiwan

Tzu-Ming Pan
Affiliation National Taiwan University
Country Taiwan
Scopus ID 7202203120
Documents 264
Citations 10,152
h-index 58
Subject Area Biology and Life Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-9865-1893

Tzu-Ming Pan is a researcher affiliated with National Taiwan University whose scholarly work is represented in the fields of biology and life sciences. The supplied Scopus record reports 264 documents, 10,152 citations, and an h-index of 58, providing a bibliometric basis for evaluating the scale and influence of the research record. The publication portfolio includes studies of probiotics, fermented functional foods, microbial safety, gut microbiota, metabolic health, and immune regulation.

Abstract

The research profile associated with Tzu-Ming Pan demonstrates sustained activity in microbiology, probiotics, functional foods, host–microbe interactions, and biological health research. Recent publications examine probiotic potential, antibiotic-associated intestinal effects, fermented red mold rice, microbial safety, inflammatory responses, and immune regulation. These studies illustrate an integrated research approach connecting microbial characterization with physiological and health-related outcomes. [1]

Keywords

Probiotics; microbiology; gut microbiota; functional foods; microbial safety; immune regulation; metabolic health; lactic acid bacteria; fermented foods; biology and life sciences.

Introduction

Microbial research increasingly addresses the relationship between microorganisms, dietary components, immunity, and host physiology. Pan’s recent publication record reflects this multidisciplinary direction, with investigations spanning probiotic strains, fermented products, microbiota, inflammatory markers, and tissue-level responses. Such work contributes to the broader scientific understanding of how beneficial microorganisms and microbial metabolites may influence biological systems. [2]

Research Profile

The research profile is centered on applied microbiological and life-science questions, particularly the characterization and evaluation of microorganisms with potential functional or health-related applications. The documented studies include Pediococcus acidilactici, Monascus pilosus, and Lacticaseibacillus paracasei, covering probiotic activity, fermented food systems, safety assessment, and immune responses. [3]

Research Contributions

  • Investigation of probiotic potential and biological effects of selected microbial strains.
  • Evaluation of fermented food components in relation to gut microbiota and metabolic health. [2]
  • Integrated genotypic and phenotypic assessment of microbial safety. [4]
  • Study of microbial interventions and immune-regulatory mechanisms in experimental models. [5]

Publications

Recent publications include research on Pediococcus acidilactici and antibiotic-induced diarrhea in Microbiology Research (2025), fermented red mold rice and metabolic health in Foods (2025), Monascus-derived compounds and tissue responses in Journal of Fungi (2024), microbial safety in Current Issues in Molecular Biology (2024), and regulatory T-cell maturation and Th1/Th2 balance in the same journal (2024). [1] [2] [3]

Research Impact

The supplied Scopus metrics indicate a substantial bibliometric footprint, with 10,152 citations and an h-index of 58 across 264 documents. These indicators provide quantitative evidence of scholarly visibility and citation activity, while individual publications demonstrate continued engagement with clinically and biologically relevant microbiological questions.

Award Suitability

Based on the supplied research record, the profile is relevant for consideration under an Innovative Research Award within the International Forensic Scientist Awards framework. The assessment may consider documented research productivity, interdisciplinary microbiological investigations, publication quality, citation impact, and the scientific relevance of contributions. Award decisions should remain subject to the applicable evaluation criteria and independent review.

Conclusion

Tzu-Ming Pan’s documented research profile reflects sustained contributions to microbiology and life sciences, particularly in probiotics, fermented foods, microbial safety, gut microbiota, and immune-related research. The combination of a broad publication record and substantial citation indicators provides a measurable basis for academic recognition, while the recent studies demonstrate continued research activity in biologically significant areas.

References

  1. MDPI. (2025). Probiotic Potential of Pediococcus acidilactici SWP-CGPA01: Alleviating Antibiotic-Induced Diarrhea and Restoring Hippocampal BDNF. Microbiology Research, 16(12), 261.
    https://doi.org/10.3390/microbiolres16120261
  2. MDPI. (2025). Effects of Monascus pilosus SWM 008-Fermented Red Mold Rice and Its Functional Components on Gut Microbiota and Metabolic Health in Rats. Foods, 14(4), 651.
    https://doi.org/10.3390/foods14040651
  3. MDPI. (2024). Comparative Effects of Monascin and Monascinol Produced by Monascus pilosus SWM-008 on Pro-Inflammatory Factors and Histopathological Alterations. Journal of Fungi, 10(12), 815.
    https://doi.org/10.3390/jof10120815
  4. MDPI. (2024). Comprehensive Safety Assessment of Lacticaseibacillus paracasei subsp. paracasei NTU 101 Through Integrated Genotypic and Phenotypic Analysis. Current Issues in Molecular Biology, 46(11), 734.
    https://doi.org/10.3390/cimb46110734
  5. MDPI. (2024). The Enhancement of Regulatory T Cell Maturation and Th1/Th2 Balance through FOXP3 Expression by Lactobacillus paracasei in an Ovalbumin-Induced Allergic Skin Animal Model. Current Issues in Molecular Biology, 46(10), 636.
    https://doi.org/10.3390/cimb46100636

Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.